Purpose <p>Patient reported outcome measures (PROMs) are key tools for monitoring and evaluating treatment effectiveness in people with bronchiectasis. However, most are developed for Anglophone contexts, limiting their applicability to non-English-speaking populations. This systematic review aimed to evaluate the measurement properties of PROMs for Spanish-speaking individuals with bronchiectasis.</p> Methods <p>A search of major databases was conducted up to August 2024, targeting studies that assessed the measurement properties (validity, reliability, and responsiveness) of any PROMs available for Spanish-speaking adults with bronchiectasis. The methodological quality of the included studies, as well as the quality of the measurement properties was evaluated according to the COSMIN (Consensus-Based Standards for the Selection of Health Status Measurement Instruments) guidelines.</p> Results <p>Of 3752 articles, four studies were included. The PROMs were the Leicester Cough Questionnaire (LCQ), Quality of Life Questionnaire for Bronchiectasis (QoL-B), COPD Assessment Test (CAT), and St. George’s Respiratory Questionnaire (SGRQ).Content validity was rated as sufficient with low or very low-quality evidence. Structural validity was assessed only for the SGRQ, rated inadequate with very low evidence. Cross-cultural validity could not be evaluated. Convergent validity was sufficient for all PROMs, highest for LCQ and QoL-B. Internal consistency was indeterminate across PROMs, though limited by lack of structural validity. Test–retest reliability was high for LCQ and moderate for QoL-B and CAT. Responsiveness was sufficient for all three PROMs assessed, with evidence quality from very low to moderate.</p> Conclusion <p>Few PROMs exist for Spanish-speaking adults with bronchiectasis. Content, structural and cultural validity, and responsiveness are the least studied properties, limiting treatment monitoring and assessment.</p> Registration <p>PROSPERO International register of systematic reviews, CRD42023388173.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Patient reported outcome measures for Spanish-speaking adults with bronchiectasis: systematic review of measurement properties

  • Yasmina Hamam-Alcober,
  • Cristina Cimarras-Otal,
  • Juan Antonio Sáez-Pérez,
  • Beatriz Herrero-Cortina

摘要

Purpose

Patient reported outcome measures (PROMs) are key tools for monitoring and evaluating treatment effectiveness in people with bronchiectasis. However, most are developed for Anglophone contexts, limiting their applicability to non-English-speaking populations. This systematic review aimed to evaluate the measurement properties of PROMs for Spanish-speaking individuals with bronchiectasis.

Methods

A search of major databases was conducted up to August 2024, targeting studies that assessed the measurement properties (validity, reliability, and responsiveness) of any PROMs available for Spanish-speaking adults with bronchiectasis. The methodological quality of the included studies, as well as the quality of the measurement properties was evaluated according to the COSMIN (Consensus-Based Standards for the Selection of Health Status Measurement Instruments) guidelines.

Results

Of 3752 articles, four studies were included. The PROMs were the Leicester Cough Questionnaire (LCQ), Quality of Life Questionnaire for Bronchiectasis (QoL-B), COPD Assessment Test (CAT), and St. George’s Respiratory Questionnaire (SGRQ).Content validity was rated as sufficient with low or very low-quality evidence. Structural validity was assessed only for the SGRQ, rated inadequate with very low evidence. Cross-cultural validity could not be evaluated. Convergent validity was sufficient for all PROMs, highest for LCQ and QoL-B. Internal consistency was indeterminate across PROMs, though limited by lack of structural validity. Test–retest reliability was high for LCQ and moderate for QoL-B and CAT. Responsiveness was sufficient for all three PROMs assessed, with evidence quality from very low to moderate.

Conclusion

Few PROMs exist for Spanish-speaking adults with bronchiectasis. Content, structural and cultural validity, and responsiveness are the least studied properties, limiting treatment monitoring and assessment.

Registration

PROSPERO International register of systematic reviews, CRD42023388173.